FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA PUBLIC CALENDAR

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

	October 3, 2005 Revised March 28, 2006
FDA Official and Title	Date and Site	Other FDA Participants	Non-FDA Participants	Subject
Lester Crawford, Acting Commissioner Food and Drugs	9/13/05, Parklawn Bldg., Rockville, MD	Janice Oliver, Sheldon Bradshaw,and Indya Mungo	ConAgra Foods: Brent Baglien, et al.	Status of Healthy Final Rule
Lester Crawford, Acting Commissioner Food and Drugs	9/13/05, Parklawn Bldg., Rockville, MD	Janice Oliver, Don Kraemer, Stephen Sundlof, Sheldon Bradshaw,Bill Jones and Indya Mungo	Southern Shrimp Alliance Board of Directors	CAP in Shrimp
Lester Crawford, Acting Commissioner Food and Drugs	9/20/05 Swizerland Bldg., Washington, DC	Scott Gottlieb, Daniel Schultz, Sheldon Bradshaw,and Wanda Russ	America's Health Insurance Plans: Karen Ignani, Stephanie Camwit, and Julie Miller	Voluntary recall of Implantable Defibrillators and Pacemakers
Lester Crawford, Acting Commissioner Food and Drugs	9/20/05 Swizerland Bldg., Washington, DC	Marlene Haffner, Jane Axelrad and Wanda Russ	NORD: Abbey Meyers and Diane Dorman	Orphan Product Medical Research, Critical Path and Funding
Janet Woodcock, M.D. Deputy Commissioner for Operations	9/20/05 Rockville, MD	Randy Levin Lisa Rovin	Rebecca Kush/ CDISC	CDISC Interchange Meeting
Janet Woodcock, M.D., Deputy Commissioner for Operations	10/3/05 Hotel Monaco Washington, DC		Lee Hartwell, Richard Caprioli, Vanderbilt University,Leigh Anderson, Plasma Proteome Institute, Dan Chan, Johns Hopkins…	National Cancer Policy Forum Speaker -  “Public-Private Partnerships to Improve Cancer Drug Development and Treatment Outcomes by Qualifying Cancer Biomarkers”
Jesse L. Goodman, MD, MPH, Director, CBER	9/29/05 Bethesda, MD	Kathryn C. Carbone, MD, Assoc. Dir. for Research, CBER	Research Review Subcommittee of Cellular, Tissue and Gene Therapies Advisory Committee Site Visit Members of the AC	Research programs in the Division of Cellular and Gene Therapy, relevance to the regulatory mission and relation to Critical Path needs. Drs. Goodman and Carbone presented an overview.
Jesse L. Goodman, MD, MPH, Director, CBER	9/29/05 Washington, DC	Other staff from DHHS	HIV Medicine Association staff	Review current issues
Sheldon T. Bradshaw, Chief Counsel	9/28/05 FDA/Rockville, MD	Gary Buehler, CDER, OGD; Elizabeth Dickinson, OCC	Paul Campanelli, Janis A. Picurro, Par Pharmaceutical, Inc.; Ed Maloney, Paddock Laboratories; Nancy Taylor, greenberg Traurig	Paddock Pending ANDA

Public Calendar Archives
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff